Article Citations

(Scroll Down for More)

A Phase 2a Trial Of Teplizumab And RN168 In Patients With New Onset Type 1 Diabetes Mellitus

Principal Investigator

Kevan Herold | Yale School of Medicine | New Haven, CT

Locations

Yale University | New Haven,CT

University of Florida | Gainesville,FL

Vanderbilt University | Nashville,TN

Barbara Davis Center | Aurora,CO

Benaroya Research Institute at Virginia Mason | Seattle,WA

Study Code

ITN831AI

Study Status

Terminated

Abstract

Qualification

Articles